Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Cohort begins May 4, 2020
Join other Clinical Development experts to receive the latest industry news, trends and insights. Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
Effective Data management plays a critical role in the conduct of clinical trials. Clinical research requires quality data...
Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...
Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...
Tags: Rare & Orphan Disease
Conducting Phase I studies is always complex. At this stage in clinical research, you are examining the tolerability of the...
In a world with COVID-19, remote monitoring is now essential to effectively monitor studies. Sponsors and CROs are either...
Tags: Pharm-Olam Insights, COVID-19
South Africa was once a commonly considered country for inclusion in clinical research, but its popularity caused bottlenecks...
Site Selection is arguably the most critical element to study success. You can have a “perfectly” designed protocol, an...
Tags: Pharm-Olam Insights
Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions with a specialization in allergy and autoimmune
Tags: Allergy & Immunology
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
